Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna StandBenzinga • 05/14/20
INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo® (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following TreatmentPRNewsWire • 05/14/20
Inovio Analysts Tackle Coronavirus Vaccine Timeline, Funding, Pipeline After Q1 ReportBenzinga • 05/12/20
Inovio Pharmaceuticals, Inc. (INO) CEO J. Joseph Kim on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/12/20
Does Inovio Pharmaceuticals Have a Successful Track Record of Developing Vaccines?The Motley Fool • 05/07/20
Inovio Is in a Race to Develop a COVID-19 Vaccine, but Can It Possibly Win?The Motley Fool • 05/01/20
Inovio to expand manufacturing of COVID-19 vaccine candidate with new CEPI grantMarket Watch • 04/30/20